DOENÇA DE ALZHEIMER (Aula Completa) - Rogério Souza

Introduction to Alzheimer's Disease

Overview of the Lecture

• The speaker, Rogério Souza, introduces the topic of Alzheimer's disease as a major neurodegenerative condition globally, second only to Parkinson's disease.

• Encourages viewers to subscribe and engage with the content before diving into the lecture.

Definition and Characteristics

• Alzheimer's disease is defined as a neurodegenerative disorder characterized by progressive neuronal death leading to cognitive and functional impairments.

• It is clinically marked by gradual memory deficits and behavioral symptoms, significantly impacting individual quality of life and family structure.

Prevalence and Types of Dementia

Understanding Dementia

• Dementia is described as a clinical syndrome with slow onset memory deficits accompanied by personality changes.

• Alzheimer’s accounts for approximately 70% of all dementia cases, overshadowing other types like frontotemporal dementia and vascular dementia.

Neurological Changes in Alzheimer's Disease

Brain Atrophy

• The disease leads to cerebral atrophy, particularly affecting the hippocampus which is crucial for recent memory acquisition.

• A visual comparison shows significant differences between healthy brains and those affected by advanced Alzheimer's, highlighting neuronal loss.

Ventricular Changes

• As brain tissue atrophies, there is an observable increase in ventricular size (ventriculomegaly), indicating compensatory changes due to neuronal death.

Cellular Impact on Memory Function

Neuronal Loss

• Alzheimer’s results in decreased nerve cells and synapses; dendrites are notably compromised which affects synaptic connections essential for memory processing.

Epidemiology of Alzheimer's Disease

Global Prevalence Statistics

• Currently, around 47 million individuals worldwide suffer from dementia; projections suggest this could triple by 2050.

• Alzheimer’s alone affects over 35 million people globally, with estimates predicting 13 million cases in the U.S. by 2050.

Etiology: Genetic vs Environmental Factors

Causes of Alzheimer's Disease

• The etiology remains partially understood but genetic factors account for about 70% of cases while environmental influences contribute to the remaining 30%.

Environmental Influences

• Exposure to toxic metals (like aluminum), pesticides, industrial chemicals, air pollutants, along with chronic infections may trigger inflammatory processes linked to Alzheimer’s development.

Diagnosis Protocol for Alzheimer's Disease

Clinical Diagnosis Approach

Understanding Alzheimer's Disease: Neuropathology and Stages

Neuropathological Changes Post-Mortem

• The diagnosis of Alzheimer's disease is confirmed post-mortem through examination of the brain, revealing specific neuropathological changes such as amyloid plaques and neurofibrillary tangles.

• Alzheimer's is characterized as a progressive disease that begins insidiously, with symptoms developing gradually over time.

Stages of Alzheimer's Disease

• The first stage is the asymptomatic phase (pre-clinical), where individuals show neuropathological changes without cognitive impairment.

• This is followed by the symptomatic phase, also known as pre-dementia, where there is noticeable cognitive decline but no functional impairment or evident dementia.

• Cognitive decline can be detected before dementia symptoms manifest, highlighting the continuous nature of the disease's progression.

Challenges in Early Diagnosis

• Diagnosing early-stage Alzheimer's can be difficult; initial cognitive decline may be mistaken for age-related changes, leading to missed opportunities for intervention.

Pathophysiology of Alzheimer’s Disease

• The pathophysiology involves abnormal deposition of beta-amyloid proteins, which leads to cell death and inflammation (cytotoxicity).

• Cytotoxicity results from excessive release of excitatory neurotransmitters causing neuronal death and mitochondrial dysfunction.

Role of Tau Protein

• Tau protein plays a crucial role in stabilizing microtubules within neurons. In healthy brains, tau maintains structural integrity; however, in Alzheimer’s patients, it becomes hyperphosphorylated and forms tangles.

• These tangles disrupt nutrient transport along axons due to destabilized microtubules, contributing to neuronal dysfunction.

Progression and Spread of Pathology

Understanding Alzheimer's Disease: Progression and Treatment

The Impact of Alzheimer's on Memory and Communication

• Alzheimer's disease is characterized by significant memory deficits, particularly affecting regions associated with learning, memory, thinking, and planning.

• In early stages, amyloid plaques form in areas related to speech and comprehension, leading to difficulties in communication and spatial awareness.

• Individuals may experience severe disorientation; for example, forgetting where they parked their car can lead to false assumptions of theft.

• In advanced stages of the disease, patients lose the ability to communicate effectively and may not recognize family members or care for themselves.

Treatment Approaches for Alzheimer's Disease

• Currently, there is no cure for Alzheimer's; treatment remains symptomatic and requires a multidisciplinary team approach.

• Cognitive impairments necessitate involvement from various professionals such as physiotherapists, psychologists, and speech therapists to enhance quality of life.

• Memantine is used as a neuroprotective agent that reduces neurotoxicity caused by excitatory neurotransmitters in the cortex.

• Cholinesterase inhibitors like donepezil are prescribed for mild to moderate cases to temporarily improve cognitive function.

Research Developments in Alzheimer’s Treatment

• Current research focuses on drugs that could slow or prevent disease progression; anti-amyloid drugs aim to reduce beta-amyloid production linked with plaque formation.

• Other investigational drugs target aggregation processes related to tau proteins characteristic of Alzheimer’s pathology but lack proven clinical efficacy at this time.

Importance of Exercise in Alzheimer’s Prevention

• A 2019 study from the Federal University of Rio de Janeiro highlighted the role of exercise-induced irisin in memory formation and neuroprotection against toxins produced during Alzheimer’s progression.

• Physical activity has been shown to counteract synaptic failure and memory impairment associated with Alzheimer’s while potentially slowing disease progression.

Variability in Disease Progression

Impact of Age and Comorbidities on Disease Progression

Key Factors Influencing Disease Course

• Age is identified as a significant factor affecting the progression of diseases.

• Comorbidities, or additional health issues, can also influence how a disease develops in individuals.

• The speaker expresses hope that the lecture has been beneficial to the audience.

• Acknowledges the effort put into preparing the material, mentioning it took nearly 15 hours of research and article compilation.